1. Academic Validation
  2. The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells

The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells

  • Carcinogenesis. 2022 Mar 24;43(2):150-159. doi: 10.1093/carcin/bgab124.
Qian Zeng 1 Fangfang Jin 1 Husun Qian 1 Hongling Chen 1 Yange Wang 1 Dian Zhang 1 Yu Wei 1 Tingmei Chen 1 Bianqin Guo 2 Chengsen Chai 1
Affiliations

Affiliations

  • 1 Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, P.R. China.
  • 2 Department of Clinical Laboratory, Chongqing University Cancer Hospital, Chongqing, P.R. China.
Abstract

Breast Cancer is the most common malignancy among women worldwide. Functional studies have demonstrated that miRNA dysregulation in many cases of Cancer, in which miRNAs act as either oncogenes or tumor suppressor. Here we report that miR-345-3p is generally upregulated in breast Cancer tissues and breast Cancer cell lines. Overexpression and inhibition of miR-345-3p revealed its capacity in regulating proliferation and invasion of breast Cancer cells. Further research identified protein Phosphatase 2 catalytic subunit alpha (PPP2CA), a suppressor of Akt phosphorylation, as a candidate target of miR-345-3p. In vitro, miR-345-3p mimics promoted Akt phosphorylation by targeting its negative regulator, PPP2CA. Blocking miR-345-3p relieved its inhibition of PPP2CA, which attenuated PI3K-AKT signaling pathway. In vivo, inhibiting miR-345-3p by miR-345-3p-inhibition lentivirus suppressed tumor growth and invasiveness in mice. Together, the miR-345-3p/PPP2CA signaling axis exhibits tumor-promoting functions by regulating proliferation and invasion of breast Cancer cells. These data provide a clue to novel therapeutic approaches for breast Cancer.

Figures
Products